Successful treatment of recurrent exit site and tunnel infections caused by atopic dermatitis with dupilumab: A case report

Ther Apher Dial. 2022 Feb;26(1):255-256. doi: 10.1111/1744-9987.13690. Epub 2021 Jun 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dermatitis, Atopic / complications*
  • Dermatitis, Atopic / drug therapy*
  • Humans
  • Japan
  • Male
  • Recurrence
  • Skin Diseases, Bacterial / drug therapy*
  • Skin Diseases, Bacterial / etiology*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • dupilumab